There is limited rigorous human data quantifying a meaningful loss of efficacy or a spike in adverse events from co-application
Current experimental literature does not indicate direct hepatotoxic effects under controlled research conditions
Last reviewed: June 6, 2026 Last updated: June 6, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
We've got you covered: The Wonders of IV Glutathione Therapy From Skin Brightening to Immune Support The benefits of boosting your glutathione levels are broad, enhancing your overall vitality
aeruginosa commonly uses low-permeability outer membranes, active efflux, and enzyme production simultaneously to resist multiple drug classes